MALVERN, Pa., Jan. 4, 2012 /PRNewswire/ -- Auxilium Pharmaceuticals, Inc. (Nasdaq: AUXL) today announced that executive management will participate in the 30th Annual J.P. Morgan Healthcare Conference to be held January 9-12, 2012 at the Westin St. Francis Hotel in San Francisco, CA. Mr. Adrian Adams, Chief Executive Officer and President, is scheduled to present an overview of the Company and its product pipeline at 2:00 p.m. PT on Thursday, January 12, 2012.
The presentation slides to be used during the call will be available on the "For Investors" section of the Auxilium web site under the "Presentations" tab on January 9, 2012. The presentation and the presentation slides will be simultaneously web cast on the "For Investors" section of the Auxilium web site under the "Events" tab on January 12, 2012. A question and answer session will follow the presentation and will be webcast. To access the live webcast, please log on to Auxilium's site approximately fifteen minutes prior to the presentation to register and download any necessary audio software. The presentation replay will be available for ninety days after the event.About AuxiliumAuxilium Pharmaceuticals, Inc. is a specialty biopharmaceutical company with a focus on developing and marketing products to predominantly specialist audiences, such as urologists, endocrinologists, certain targeted primary care physicians, hand surgeons, subsets of orthopedic, general, and plastic surgeons who focus on the hand, and rheumatologists. Auxilium markets XIAFLEX® (collagenase clostridium histolyticum) for the treatment of adult Dupuytren's contracture patients with a palpable cord and Testim® 1%, a testosterone gel, for the topical treatment of hypogonadism in the U.S. Pfizer has marketing rights for XIAPEX® (the EU trade
|SOURCE Auxilium Pharmaceuticals, Inc.|
Copyright©2010 PR Newswire.
All rights reserved